Promentis Pharmaceuticals

OverviewSuggest Edit

Promentis Pharmaceuticals, Inc., is a privately held biopharmaceutical company focused on the discovery and development of first-in-class therapies to treat central nervous system (CNS) disorders.
Promentis’ drug development program is focused on activating a unique target known to restore glutamatergic neurotransmission and imbalances in oxidative stress, key contributors to impaired cortical function linked to multiple CNS disorders.
The Company’s lead compound, SXC-2023, is being developed to treat various psychiatric disorders, with an initial focus on an indication that, despite representing a common disorder affecting millions of patients, has no FDA-approved treatment and a high level of patient need.

TypePrivate
Founded2006
HQMilwaukee, US
Websitepromentispharma.com

Latest Updates

Employees (est.) (Sep 2019)6

Key People/Management at Promentis Pharmaceuticals

Klaus Veitinger

Klaus Veitinger

CEO
Thomas R. Beck

Thomas R. Beck

Chief Medical Officer
Michael P. Neary

Michael P. Neary

Director of Research
Stacy Holland

Stacy Holland

Vice President of Finance
Show more

Promentis Pharmaceuticals Office Locations

Promentis Pharmaceuticals has an office in Milwaukee
Milwaukee, US (HQ)
826 N Plankinton Ave
Show all (1)

Promentis Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

2006

Promentis Pharmaceuticals total Funding

$43.8 m

Promentis Pharmaceuticals latest funding size

$26 m

Time since last funding

2 years ago

Promentis Pharmaceuticals investors

Promentis Pharmaceuticals's latest funding round in March 2017 was reported to be $26 m. In total, Promentis Pharmaceuticals has raised $43.8 m
Show all financial metrics

Promentis Pharmaceuticals Online and Social Media Presence

Embed Graph

Promentis Pharmaceuticals News and Updates

Promentis Pharmaceuticals to present at the 57th annual American College of Neuropsychopharmacology (ACNP) meeting

MILWAUKEE, Dec. 5, 2018 /PRNewswire/ -- Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, announced that Senior Vice President of R&D, Dr. Chad Beyer, will present nonclinical data and initial...

Promentis Pharmaceuticals Announces Successful Completion of Phase 1 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism

MILWAUKEE, Nov. 16, 2018 /PRNewswire/ -- Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, today announced it has completed Phase 1 single ascending dose and multiple ascending dose studies for its...

Promentis Pharmaceuticals to present at the Society for Neuroscience conference

MILWAUKEE, Wis., Oct. 29, 2018 /PRNewswire/ -- Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, announced today that Dr. Chad Beyer and Michael Neary will present key scientific data on SXC-2023, a...

Promentis Pharmaceuticals Blogs

Promentis Pharmaceuticals Announces Commencement of Phase 2 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism

Company has initiated Phase 2 monotherapy study in trichotillomania and prepares for a Phase 2 add-on therapy study in OCD   Milwaukee, Wisconsin | January 17, […]

Promentis Pharmaceuticals Frequently Asked Questions

  • When was Promentis Pharmaceuticals founded?

    Promentis Pharmaceuticals was founded in 2006.

  • Who are Promentis Pharmaceuticals key executives?

    Promentis Pharmaceuticals's key executives are Klaus Veitinger, Thomas R. Beck and Michael P. Neary.

  • How many employees does Promentis Pharmaceuticals have?

    Promentis Pharmaceuticals has 6 employees.

  • Who are Promentis Pharmaceuticals competitors?

    Competitors of Promentis Pharmaceuticals include Inovio Pharmaceuticals, Athersys and Otonomy.

  • Where is Promentis Pharmaceuticals headquarters?

    Promentis Pharmaceuticals headquarters is located at 826 N Plankinton Ave, Milwaukee.

  • Where are Promentis Pharmaceuticals offices?

    Promentis Pharmaceuticals has an office in Milwaukee.

  • How many offices does Promentis Pharmaceuticals have?

    Promentis Pharmaceuticals has 1 office.